alexa A New And Effective Treatment For Dengue Fever
ISSN: 2327-5073

Clinical Microbiology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Clinical Microbiology & Microbial Genomics
September 24-26, 2014 Valencia Convention Centre, Spain

Max Reynolds
Keynote: Clin Microbial
DOI: 10.4172/2327-5073.S1.012
Abstract
For over the last 50 years plus the scientific world has been trying to find a way to stop dengue fever without much success until now. The problem has been to kill all 4 different strains of the virus which cause this disease without injuring the patient in the process. There have been some major expensive failures in the arena of vaccine production. Now we have a specialist Australian based company who has developed, from a plant extract, a compound which kills all 4 strains and is safe for human use. The author and his team have carried out all 3 phase studies successfully over the last 8 years and have most recently achieved, in a Double Blind 540 patients trial at the University of Airlungga in Indonesia, have achieved a 96.6% kill rate of all 4 virus within 3 days and at the same time increased the CD4 (helper cells) and CD8 (killer cells) immune elements within the patients by 64.4%. These results have been achieved by the use of a plant extract from the Melaleuca alternifolia tree, a native of Australia, from which they have removed, by a patented system, 90% of the mono terpenes and made the active compounds safe for human oral consumption. The compounds dissolve the outer envelope which covers the virus and then proceeds to kill the virus directly. With this drug dengue will be a disease of the past as soon as it reaches the worlds medical centers where dengue is of major importance.
Biography
Max Reynolds has over half a century of global experience in scientific research, business and product development. His commitment and determination to exploring biotechnology and discovering new practical uses for it has led to many advances, including the development of 98alive?, which is produced by 98 Alive Pty Ltd of which Professor Reynolds is also the Managing Director. He has previously lectured at leading Australian university, Griffith University in Brisbane, Queensland and has held the position of Director of the Program in Australasia Botanical Medicine for Population Health.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords